James Investment Research’s Axcelis ACLS Stock Holding History

James Investment Research’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$317K	Sell	3,408 -4,873	-59%	-$432K	0.04%	292
2025 Q4	$665K	Hold	8,281	–	–	0.07%	209
2025 Q3	$809K	Buy	8,281 +4,305	+108%	+$347K	0.09%	185
2025 Q2	$277K	Buy	+3,976	New	+$227K	0.03%	281
2025 Q1	–	Sell	-3,976	Closed	-$278K	–	327
2024 Q4	$278K	Hold	3,976	–	–	0.03%	276
2024 Q3	$417K	Hold	3,976	–	–	0.05%	237
2024 Q2	$565K	Buy	3,976 +1,008	+34%	+$116K	0.07%	203
2024 Q1	$331K	Buy	+2,968	New	+$354K	0.04%	255
2018 Q1	–	Sell	-50,800	Closed	-$1.46M	–	775
2017 Q4	$1.46M	Buy	+50,800	New	+$1.6M	0.05%	442

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

James Investment Research's ACLS Position: Q1 2026 in Review

James Investment Research reduced its Axcelis (ACLS) stake by 59% in Q1 2026, selling an estimated $432K and leaving 3,408 shares worth $317K. The position accounts for 0.04% of the portfolio, ranked #292.

James Investment Research first reported a position in ACLS in Q4 2017 and has held it in 9 quarters since. The position peaked at $1.46M in Q4 2017. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

James Investment Research held 3,408 shares of Axcelis worth $317K as of Q1 2026.
James Investment Research sold 4,873 Axcelis shares in Q1 2026, an estimated $432K.
Axcelis made up 0.04% of James Investment Research's portfolio in Q1 2026, its #292 holding.
James Investment Research first reported a position in Axcelis in Q4 2017 and has held it in 9 quarters since.
James Investment Research's Axcelis position peaked at $1.46M in Q4 2017.
377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on James Investment Research's 13F filing for Q1 2026, filed 24 Apr 2026.